Log In
BCIQ
Print this Print this
 

ICEF15

  Manage Alerts
Collapse Summary General Information
Company Innovacell Biotechnologie AG
DescriptionCell therapy product based on proliferating autologous myoblasts from a biopsy taken from patients' own muscle
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat fecal incontinence
Regulatory Designation
PartnerNorgine B.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/23/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today